NCT01585025 - Obeticholic Acid in Bile Acid Diarrhoea | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

February 28, 2014

Conditions

Primary Bile Acid MalabsorptionSecondary Bile Acid MalabsorptionChronic Diarrhoea

Interventions

DRUG

Obeticholic acid

Day -14 to Day 0 subjects will stop their usual diarrhoeal medication. Day 1 to Day 15 Obeticholic acid 25mg tablet will be administered to subjects once daily in the morning. Day 16 to day 28 normal diarrhoeal medication may be re-commenced.

Trial Locations (2)

W12 0HS

Hammersmith Hospital, Imperial College Healthcare NHS Trust, London

Hammersmith Hospital, London

All Listed Sponsors

lead

Imperial College Healthcare NHS Trust

OTHER